15 employees
GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.
2017
$4.8M
from 1 investors over 1 rounds
GPN Vaccines raised $4.8M on June 30, 2020
Investors: Forepont Capital Partners